Mukund S Chorghade

Title: Mukund S Chorghade: Innovator in Pharmaceutical Development

Introduction

Mukund S Chorghade is a notable inventor based in Gurnee, IL (US). He has made significant contributions to the field of pharmaceutical development, holding 2 patents that focus on innovative methods for drug metabolite identification and synthesis.

Latest Patents

Chorghade's latest patents include a method for the systematic and efficient synthetic preparation and identification of metabolites of pharmaceutical products. This method aims to study possible toxic and biologically-active metabolites early in the drug development process. It involves adding samples of the pharmaceutical product to various combinations of synthetic metalloporphyrins and co-oxidizing reagents in a suitable solvent. The process allows for the separation and isolation of oxidative products, followed by confirmation of metabolite identities through animal model studies.

Another significant patent is a novel process for preparing enantiomerically-pure 3-methyl-5-(1-(C.sub.1 -C.sub.3 -alkyl)-2-pyrrolidinyl)isoxazole in high yield. This process utilizes a protected pyrrolidine or 2-oxo-pyrrolidine starting material, which is reacted with a suitable organic anion to produce a beta-keto oxime intermediate that is cyclized and dehydrated.

Career Highlights

Chorghade is currently associated with Abbott Laboratories Corporation, where he continues to innovate in the pharmaceutical sector. His work focuses on enhancing the efficiency and effectiveness of drug development processes.

Collaborations

He has collaborated with notable coworkers such as Steven J Wittenberger and Yun He, contributing to advancements in their respective fields.

Conclusion

Mukund S Chorghade's innovative approaches in pharmaceutical development highlight his commitment to improving drug safety and efficacy. His patents reflect a deep understanding of complex chemical processes, making him a valuable asset in the industry.